Literature DB >> 16714638

Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology.

Zhi-Hui Fan1, Min-Hua Chen, Ying Dai, Yan-Bin Wang, Kun Yan, Wei Wu, Wei Yang, Shan-Shan Yin.   

Abstract

OBJECTIVE: Our purpose was to investigate the correlation of contrast-enhanced sonographic patterns with the histopathology of primary malignancies of the liver.
MATERIAL AND METHODS: Of the 318 contrast-enhanced sonographic examinations performed between April and September 2004, 95 patients with 117 lesions confirmed by surgery or biopsy pathology were reviewed in this study. We analyzed the enhancement time and patterns according to the types and degrees of pathologic differentiation.
RESULTS: All 65 moderately to poorly differentiated hepatocellular carcinomas (HCCs) enhanced in the arterial phase, and 96.9% (63 lesions) of them quickly washed out in the portal venous phase. All 32 well-differentiated HCCs enhanced in the arterial phase, and 50.0% (16 lesions) washed out slowly during the late phase. The washout time of the two differentiated types was significantly different (p < 0.05). Seventy-five percent of the clear cell carcinomas (12/16) enhanced in the arterial phase, 25% (4/16) did not enhance until the portal venous phase, and 31.3% (5/16) of the clear cell carcinomas washed out slowly during the late phase. The enhancement and washout times of clear cell carcinomas were significantly different than those of moderately to poorly differentiated HCCs (p < 0.05). All four intrahepatic cholangiocarcinomas presented the same patterns as moderately to poorly differentiated HCCs: enhanced in the arterial phase and quickly washed out in the portal venous phase. Among the 72 lesions enhanced homogeneously, 46 lesions (63.9%) were smaller than 3 cm. Thirty-seven lesions (82.2%) of the 45 lesions that enhanced heterogeneously were larger than 3 cm (including the four cholangiocarcinomas). Larger lesions were mainly less differentiated. There were significant differences in tumor sizes in regard to cellular differentiations and types.
CONCLUSION: Our study showed that the enhancement manifestations of primary malignancies of the liver are related to pathologic types and grades. Contrast-enhanced sonograms may provide the histopathologic information for malignant tumors of the liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714638     DOI: 10.2214/AJR.05.0943

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  19 in total

1.  Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and histological grading.

Authors:  X Q Pei; L Z Liu; M Liu; W Zheng; F Han; A H Li; M Y Cai
Journal:  Br J Radiol       Date:  2011-11-17       Impact factor: 3.039

2.  Computer-aided diagnosis for contrast-enhanced ultrasound in the liver.

Authors:  Katsutoshi Sugimoto; Junji Shiraishi; Fuminori Moriyasu; Kunio Doi
Journal:  World J Radiol       Date:  2010-06-28

Review 3.  Contrast-enhanced ultrasound in liver cancer.

Authors:  Simona Leoni; Ilaria Serio; Anna Pecorelli; Sara Marinelli; Luigi Bolondi
Journal:  Hepat Oncol       Date:  2015-01-12

Review 4.  [Diagnostic imaging of liver tumours. Current status].

Authors:  B Boozari; J Lotz; M Galanski; M Gebel
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

5.  Comparing enhancement and washout patterns of hepatic lesions between sonazoid-enhanced ultrasound and contrast-enhanced computed tomography.

Authors:  Sneha Patel; Akiko Saito; Yuki Yoneda; Toshio Hayano; Keiko Shiratori
Journal:  J Med Ultrason (2001)       Date:  2010-07-27       Impact factor: 1.314

Review 6.  Imaging Diagnosis of Hepatocellular Carcinoma: Recent Advances of Contrast-Enhanced Ultrasonography with SonoVue®.

Authors:  Veronica Salvatore; Alice Gianstefani; Giulia Negrini; Giulia Allegretti; Marzia Galassi; Fabio Piscaglia
Journal:  Liver Cancer       Date:  2015-12-18       Impact factor: 11.740

Review 7.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 8.  Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu
Journal:  World J Radiol       Date:  2014-01-28

Review 9.  Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions.

Authors:  Stanislas-H Morin; Adrian-Kp Lim; Jeremy-Fl Cobbold; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

10.  Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis.

Authors:  Emilio Quaia; Mirko D'Onofrio; Paolo Cabassa; Francesca Vecchiato; Sabrina Caffarri; Frida Pittiani; Knut M Wittkowski; Maria Assunta Cova
Journal:  AJR Am J Roentgenol       Date:  2007-12       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.